TLR3-primed ADSC exosomes reverse osteoarthritis through PSMD14-mediated K63-linked deubiquitination of fibrillarin
Open Access
- 14 November 2026
- journal article
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 61
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- PSMD14 Stabilizes SLC7A11 to Ameliorate Glucocorticoid‐Induced Osteoporosis by Suppressing Osteocyte FerroptosisAdvanced Science, 2025
- Toll-like receptor activation regulates the paracrine effect of adipose-derived mesenchymal stem cells on reversing osteoarthritic phenotype of chondrocytesMolecular Biology Reports, 2024
- The proteasome component PSMD14 drives myelomagenesis through a histone deubiquitinase activityMolecular Cell, 2023
- Evaluation and Treatment of Knee PainJAMA, 2023
- Research progress in the use of mesenchymal stem cells and their derived exosomes in the treatment of osteoarthritisAgeing Research Reviews, 2022
- Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2Molecular Oncology, 2021
- Characteristics of sensory innervation in synovium of rats within different knee osteoarthritis models and the correlation between synovial fibrosis and hyperalgesiaJournal of Advanced Research, 2021
- The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritisAgeing Research Reviews, 2021
- Nascent Pre-rRNA Sorting via Phase Separation Drives the Assembly of Dense Fibrillar Components in the Human NucleolusMolecular Cell, 2019
- SIRT7-Dependent Deacetylation of Fibrillarin Controls Histone H2A Methylation and rRNA Synthesis during the Cell CycleCell Reports, 2018